Moderna, Inc. (MRNA)

Last Closing Price: 125.59 (2024-05-02)

Long-Term Liabilities (Annual)

Long-Term Liabilities: The sum of all non-current liabilities.

Moderna, Inc. (MRNA) had Long-Term Liabilities of $1.56B for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$6.85B
$-4.71B
$4.69B
$2.15B
$11.09B
$-4.24B
$297.00M
$-3.94B
$-3.94B
$-4.71B
$-4.71B
$-4.71B
$-4.71B
$-4.24B
$-3.68B
382.00M
382.00M
$-12.33
$-12.33
Balance Sheet Financials
$10.32B
$1.95B
$8.10B
$18.43B
$3.02B
$575.00M
Long-Term Liabilities
$1.56B
$4.57B
$13.85B
$13.85B
$13.85B
382.00M
Cash Flow Statement Financials
$-3.12B
$4.21B
$-1.38B
$3.22B
$2.93B
$-289.00M
$305.00M
--
--
Fundamental Metrics & Ratios
3.42
--
--
0.04
0.04
31.47%
-61.90%
-61.90%
-53.72%
-57.56%
-68.84%
$-3.83B
--
--
--
0.37
23.23
7.68
47.54
-34.03%
-34.03%
-25.58%
-32.67%
$36.27
$-10.01
$-8.16